Kang M, Zanin M, Wong SS. Subtype H3N2 Influenza A Viruses: An Unmet Challenge in the Western Pacific. Vaccines (Basel). 2022 Jan 12;10(1):112
Subtype H3N2 influenza A viruses (A(H3N2)) have been the dominant strain in some countries in the Western Pacific region since the 2009 influenza A(H1N1) pandemic. Vaccination is the most effective way to prevent influenza; however, low vaccine effectiveness has been reported in some influenza seasons, especially for A(H3N2). Antigenic mismatch introduced by egg-adaptation during vaccine production between the vaccine and circulating viral stains is one of the reasons for low vaccine effectiveness. Here we review the extent of this phenomenon, the underlying molecular mechanisms and discuss recent strategies to ameliorate this, including new vaccine platforms that may provide better protection and should be considered to reduce the impact of A(H3N2) in the Western Pacific region.
See Also:
Latest articles in those days:
- Duck CD8 + T Cell Response to H5N1 Highly Pathogenic Avian Influenza Virus Infection In Vivo and In Vitro 2 days ago
- Early risk of acute myocardial infarction following hospitalization for severe influenza infection in the middle-aged population of Hong Kong 2 days ago
- Understanding the rebound of influenza in the post COVID19 pandemic period holds important clues for epidemiology and control 4 days ago
- Evaluation of PCR-Based Hemagglutinin Subtyping as a Tool to aid in Surveillance of Avian Influenza viruses in Migratory Wild Birds 4 days ago
- Influenza virus NS1 interacts with 14-3-3ε to antagonize the production of RIG-I-mediated type I interferons 6 days ago
[Go Top] [Close Window]